Page last updated: 2024-10-27

gabexate and Acantholysis

gabexate has been researched along with Acantholysis in 2 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Acantholysis: Separation of the prickle cells of the stratum spinosum of the epidermis, resulting in atrophy of the prickle cell layer. It is seen in diseases such as pemphigus vulgaris (see PEMPHIGUS) and DARIER DISEASE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, S1
Ogawa, H1
Naito, K1

Other Studies

2 other studies available for gabexate and Acantholysis

ArticleYear
Effects of steroid, retinoid, and protease inhibitors on the formation of acantholysis induced in organ culture of skins from patients with benign familial chronic pemphigus.
    The Journal of investigative dermatology, 1991, Volume: 97, Issue:4

    Topics: Acantholysis; Adult; Betamethasone; Diterpenes; Esters; Female; Gabexate; Guanidines; Humans; Male;

1991
[The identification of inhibitors of acantholysis of pemphigus vulgaris].
    Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology, 1987, Volume: 97, Issue:11

    Topics: Acantholysis; Animals; Fibrinolysin; Gabexate; Guanidines; Humans; Mice; Mice, Inbred BALB C; Pemphi

1987